Guests from various industries discuss US economic data, airline earnings, pharmaceutical company performance, and commercial real estate in an engaging and insightful conversation on the podcast.

Astrazeneca CFO, Aradhana Sarin, discusses the company's goal to double sales by 2030 and launch 20 new medicines. They explore strategic growth plans in oncology, rare diseases, metabolic disorders, and respiratory issues. The podcast also delves into corporate investments, shareholder returns, drug development strategies, and challenges of geopolitical tensions and supply chain resilience for AstraZeneca.